REVVITY, INC., PRE 14A filed on 3/6/2026
Proxy Statement - Notice of Shareholders Meeting (preliminary)
v3.25.4
Cover
 12 Months Ended
Dec. 31, 2025
Document Information [Line Items]  
Document Type PRE 14A
Amendment Flag false
Entity Information [Line Items]  
Entity Registrant Name Revvity, Inc.
Entity Central Index Key 0000031791
v3.25.4
Pay vs Performance Disclosure
 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Pay Versus Performance
In accordance with rules adopted by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and
Non-PEO
named executive officers
(“Non-PEO
NEOs”) and Company performance for the fiscal years listed below.
 
Year
  
Summary
Compensation Table
Total for Prahlad R.
Singh¹
($)
  
Compensation
Actually Paid
to Prahlad R.
Singh
1,2,3
($)
  
Average
Summary
Compensation
Table Total
for
Non-PEO

NEOs
1
($)
  
Average
Compensation
Actually Paid
to
Non-PEO

NEOs
1,2,3

($)
  
Value of Initial
Fixed $100
Investment Based
On:
4
  
Net
Income
($ Millions)
  
Average
 Non-COVID

  Organic
Revenue
Growth
 
TSR
($)
  
Peer
Group
TSR
($)
2025
    
 
13,809,549
      
 
5,799,936
      
 
3,944,143
      
 
2,320,920
      
 
68.20
      
 
105.15
      
 
241
      
 
1.9
%
2024
    
 
11,926,615
      
 
11,462,997
      
 
2,853,563
      
 
2,874,292
      
 
78.72
      
 
100.04
      
 
270
      
 
4.1
%
2023
    
 
9,130,624
      
 
3,649,837
      
 
2,216,350
      
 
1,319,296
      
 
76.63
      
 
103.66
      
 
693
      
 
9.1
%
2022
    
 
10,576,998
      
 
1,806,595
      
 
2,074,392
      
 
(698,239
)
    
 
98.08
      
 
106.95
      
 
569
      
 
6.2
%
2021
    
 
9,661,006
      
 
22,364,293
      
 
2,401,828
      
 
5,469,748
      
 
140.37
      
 
138.73
      
 
943
      
 
4.8
%
 
1.
Prahlad R. Singh was our PEO for each year presented. The individuals comprising the
Non-PEO
NEOs for each year presented are listed below.
 
2021
  
2022
  
2023
  
2024
  
2025
James M. Mock
   James M. Mock   Maxwell Krakowiak   Maxwell Krakowiak   Maxwell Krakowiak
Joel S. Goldberg
   Joel S. Goldberg   Joel S. Goldberg   Joel S. Goldberg   Joel S. Goldberg
Daniel R. Tereau
   Daniel R. Tereau   Tajinder S. Vohra   Tajinder S. Vohra   Miriame Victor
Tajinder S. Vohra
   Tajinder S. Vohra   Miriame Victor   Miriame Victor   Tajinder S. Vohra
 
   Maxwell Krakowiak  
 
  
 
  
 
 
2.
The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation
S-K
and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
 
3.
Compensation Actually Paid for 2025 reflects the exclusions and inclusions of certain amounts for the PEO and the
Non-PEO
NEOs as set forth below. Equity values are calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.
 
Year
  
Summary Compensation
Table Total for Prahlad
R. Singh
($)
  
Exclusion of Stock Awards
and Option Awards for
Prahlad R. Singh
($)
  
Inclusion of Equity Values
for Prahlad R. Singh
($)
  
Compensation Actually
 Paid to Prahlad R. Singh 
($)
2025
       13,809,549       (10,254,137 )       2,244,524       5,799,936
 
Year
  
Average Summary
Compensation Table
Total for
Non-PEO

NEOs
($)
  
Average Exclusion of
Stock Awards
and Option Awards
for
Non-PEO
NEOs
($)
  
Average Inclusion of Equity
Values for
Non-PEO
NEOs
($)
  
 Average Compensation 
Actually Paid to
Non-PEO
NEOs
($)
2025
       3,944,143       (2,820,390 )       1,197,167       2,320,920
 
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
 
Year
  
Year-End Fair Value

of Equity Awards
Granted During
Year That
Remained
Unvested as of Last
Day of Year for
Prahlad R. Singh
($)
  
Change in Fair Value
from
Last Day of
Prior Year to
Last Day of Year
of Unvested
Equity Awards
for Prahlad R. Singh
($)
  
Change in Fair Value
from Last Day of
Prior Year to
Vesting Date of
Unvested
Equity Awards
that Vested
During Year
for Prahlad R. Singh
($)
  
 Total -Inclusion of 
Equity Values for
Prahlad R. Singh
($)
2025
       7,500,182       (5,462,311 )       206,653       2,244,524
 
Year
   
Average
Year-End Fair

Value of Equity
Awards
Granted
During Year
That Remained
Unvested
as of Last Day
of Year for
Non-PEO NEOs
($)
   
Average Change
in Fair
Value from Last
Day of Prior
Year to Last Day
of Year of
Unvested
Equity Awards for
Non-PEO
NEOs
($)
  
Average Change
in Fair Value
from Last Day
of Prior Year to
Vesting Date of
Unvested
Equity
Awards that
Vested During
Year for
Non-PEO
NEOs
($)
   
Total - Average
Inclusion of
 Equity Values for 
Non-PEO
NEOs
($)
2025
        2,282,894        (1,094,425 )       8,698        1,197,167
 
4.
The Peer Group TSR set forth in this table utilizes the S&P 500 Life Sciences Tools & Services Industry Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation
S-K
included in our Annual Report for the fiscal year ended December 28, 2025. The comparison assumes $100 was invested for the period starting January 3, 2021, through the end of the listed year in the Company and in the S&P 500 Life Sciences Tools & Services Industry Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
 
5.
We determined average
Non-COVID
Organic Revenue Growth to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and
Non-PEO
NEOs in 2025. Average
Non-COVID
Organic Revenue Growth is a
non-GAAP
financial measure and is calculated using revenue reported in our audited financial statements, adjusted as described in the “Determining Executive Pay” section of the Compensation Discussion and Analysis.
       
Company Selected Measure Name Average  Non-COVID  Organic Revenue Growth        
Named Executive Officers, Footnote
1.
Prahlad R. Singh was our PEO for each year presented. The individuals comprising the
Non-PEO
NEOs for each year presented are listed below.
 
2021
  
2022
  
2023
  
2024
  
2025
James M. Mock
   James M. Mock   Maxwell Krakowiak   Maxwell Krakowiak   Maxwell Krakowiak
Joel S. Goldberg
   Joel S. Goldberg   Joel S. Goldberg   Joel S. Goldberg   Joel S. Goldberg
Daniel R. Tereau
   Daniel R. Tereau   Tajinder S. Vohra   Tajinder S. Vohra   Miriame Victor
Tajinder S. Vohra
   Tajinder S. Vohra   Miriame Victor   Miriame Victor   Tajinder S. Vohra
 
   Maxwell Krakowiak  
 
  
 
  
 
        
Peer Group Issuers, Footnote The Peer Group TSR set forth in this table utilizes the S&P 500 Life Sciences Tools & Services Industry Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation
S-K
included in our Annual Report for the fiscal year ended December 28, 2025. The comparison assumes $100 was invested for the period starting January 3, 2021, through the end of the listed year in the Company and in the S&P 500 Life Sciences Tools & Services Industry Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. 		       
PEO Total Compensation Amount $ 13,809,549 $ 11,926,615 $ 9,130,624 $ 10,576,998 $ 9,661,006
PEO Actually Paid Compensation Amount $ 5,799,936 11,462,997 3,649,837 1,806,595 22,364,293
Adjustment To PEO Compensation, Footnote
3.
Compensation Actually Paid for 2025 reflects the exclusions and inclusions of certain amounts for the PEO and the
Non-PEO
NEOs as set forth below. Equity values are calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.
 
Year
  
Summary Compensation
Table Total for Prahlad
R. Singh
($)
  
Exclusion of Stock Awards
and Option Awards for
Prahlad R. Singh
($)
  
Inclusion of Equity Values
for Prahlad R. Singh
($)
  
Compensation Actually
 Paid to Prahlad R. Singh 
($)
2025
       13,809,549       (10,254,137 )       2,244,524       5,799,936
 
Year
  
Average Summary
Compensation Table
Total for
Non-PEO

NEOs
($)
  
Average Exclusion of
Stock Awards
and Option Awards
for
Non-PEO
NEOs
($)
  
Average Inclusion of Equity
Values for
Non-PEO
NEOs
($)
  
 Average Compensation 
Actually Paid to
Non-PEO
NEOs
($)
2025
       3,944,143       (2,820,390 )       1,197,167       2,320,920
 
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
 
Year
  
Year-End Fair Value

of Equity Awards
Granted During
Year That
Remained
Unvested as of Last
Day of Year for
Prahlad R. Singh
($)
  
Change in Fair Value
from
Last Day of
Prior Year to
Last Day of Year
of Unvested
Equity Awards
for Prahlad R. Singh
($)
  
Change in Fair Value
from Last Day of
Prior Year to
Vesting Date of
Unvested
Equity Awards
that Vested
During Year
for Prahlad R. Singh
($)
  
 Total -Inclusion of 
Equity Values for
Prahlad R. Singh
($)
2025
       7,500,182       (5,462,311 )       206,653       2,244,524
 
Year
   
Average
Year-End Fair

Value of Equity
Awards
Granted
During Year
That Remained
Unvested
as of Last Day
of Year for
Non-PEO NEOs
($)
   
Average Change
in Fair
Value from Last
Day of Prior
Year to Last Day
of Year of
Unvested
Equity Awards for
Non-PEO
NEOs
($)
  
Average Change
in Fair Value
from Last Day
of Prior Year to
Vesting Date of
Unvested
Equity
Awards that
Vested During
Year for
Non-PEO
NEOs
($)
   
Total - Average
Inclusion of
 Equity Values for 
Non-PEO
NEOs
($)
2025
        2,282,894        (1,094,425 )       8,698        1,197,167
       
Non-PEO NEO Average Total Compensation Amount $ 3,944,143 2,853,563 2,216,350 2,074,392 2,401,828
Non-PEO NEO Average Compensation Actually Paid Amount $ 2,320,920 2,874,292 1,319,296 (698,239) 5,469,748
Adjustment to Non-PEO NEO Compensation Footnote
3.
Compensation Actually Paid for 2025 reflects the exclusions and inclusions of certain amounts for the PEO and the
Non-PEO
NEOs as set forth below. Equity values are calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.
 
Year
  
Summary Compensation
Table Total for Prahlad
R. Singh
($)
  
Exclusion of Stock Awards
and Option Awards for
Prahlad R. Singh
($)
  
Inclusion of Equity Values
for Prahlad R. Singh
($)
  
Compensation Actually
 Paid to Prahlad R. Singh 
($)
2025
       13,809,549       (10,254,137 )       2,244,524       5,799,936
 
Year
  
Average Summary
Compensation Table
Total for
Non-PEO

NEOs
($)
  
Average Exclusion of
Stock Awards
and Option Awards
for
Non-PEO
NEOs
($)
  
Average Inclusion of Equity
Values for
Non-PEO
NEOs
($)
  
 Average Compensation 
Actually Paid to
Non-PEO
NEOs
($)
2025
       3,944,143       (2,820,390 )       1,197,167       2,320,920
 
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
 
Year
  
Year-End Fair Value

of Equity Awards
Granted During
Year That
Remained
Unvested as of Last
Day of Year for
Prahlad R. Singh
($)
  
Change in Fair Value
from
Last Day of
Prior Year to
Last Day of Year
of Unvested
Equity Awards
for Prahlad R. Singh
($)
  
Change in Fair Value
from Last Day of
Prior Year to
Vesting Date of
Unvested
Equity Awards
that Vested
During Year
for Prahlad R. Singh
($)
  
 Total -Inclusion of 
Equity Values for
Prahlad R. Singh
($)
2025
       7,500,182       (5,462,311 )       206,653       2,244,524
 
Year
   
Average
Year-End Fair

Value of Equity
Awards
Granted
During Year
That Remained
Unvested
as of Last Day
of Year for
Non-PEO NEOs
($)
   
Average Change
in Fair
Value from Last
Day of Prior
Year to Last Day
of Year of
Unvested
Equity Awards for
Non-PEO
NEOs
($)
  
Average Change
in Fair Value
from Last Day
of Prior Year to
Vesting Date of
Unvested
Equity
Awards that
Vested During
Year for
Non-PEO
NEOs
($)
   
Total - Average
Inclusion of
 Equity Values for 
Non-PEO
NEOs
($)
2025
        2,282,894        (1,094,425 )       8,698        1,197,167
       
Compensation Actually Paid vs. Total Shareholder Return
Description of Relationship Between PEO and
Non-PEO
NEO Compensation Actually Paid and Company Total Shareholder Return (“TSR”) and Peer Group TSR
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our
Non-PEO
NEOs, the Company’s cumulative TSR over the five most recently completed fiscal years and the TSR of the S&P 500 Life Sciences Tools & Services Industry Index over the same period.
 
 
LOGO
       
Compensation Actually Paid vs. Net Income
Description of Relationship Between PEO and
Non-PEO
NEO Compensation Actually Paid and Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our
Non-PEO
NEOs, and our Net Income during the five most recently completed fiscal years.
 
 
LOGO
 
        
Compensation Actually Paid vs. Company Selected Measure
Description of Relationship Between PEO and Other NEO Compensation Actually Paid
and
Adjusted Revenue
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our other
Non-PEO
NEOs, and our Adjusted Revenue during the five most recently completed fiscal years.
 
 
LOGO
       
Total Shareholder Return Vs Peer Group
Description of Relationship Between PEO and
Non-PEO
NEO Compensation Actually Paid and Company Total Shareholder Return (“TSR”) and Peer Group TSR
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our
Non-PEO
NEOs, the Company’s cumulative TSR over the five most recently completed fiscal years and the TSR of the S&P 500 Life Sciences Tools & Services Industry Index over the same period.
 
 
LOGO
       
Tabular List, Table
Tabular List of Most
Important
Financial Performance Measures
The following table presents the financial performance measures that the Company considers to have been the most important in linking Compensation Actually Paid to our PEO and other
Non-PEO
NEOs for 2025 to Company performance. The measures in this table are not ranked.
 
Average
Non-COVID
Organic Revenue Growth
Adjusted Operating Margin Expansion
Organic Revenue Growth
Adjusted EPS
Free Cash Flow Conversion
        
Total Shareholder Return Amount $ 68.2 78.72 76.63 98.08 140.37
Peer Group Total Shareholder Return Amount 105.15 100.04 103.66 106.95 138.73
Net Income (Loss) $ 241,000,000 $ 270,000,000 $ 693,000,000 $ 569,000,000 $ 943,000,000
Company Selected Measure Amount 1.9 4.1 9.1 6.2 4.8
PEO Name Prahlad R. Singh        
Measure:: 1          
Pay vs Performance Disclosure          
Name Average Non-COVID Organic Revenue Growth        
Non-GAAP Measure Description We determined average
Non-COVID
Organic Revenue Growth to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and
Non-PEO
NEOs in 2025. Average
Non-COVID
Organic Revenue Growth is a
non-GAAP
financial measure and is calculated using revenue reported in our audited financial statements, adjusted as described in the “Determining Executive Pay” section of the Compensation Discussion and Analysis. 		       
Measure:: 2          
Pay vs Performance Disclosure          
Name Adjusted Operating Margin Expansion        
Measure:: 3          
Pay vs Performance Disclosure          
Name Organic Revenue Growth        
Measure:: 4          
Pay vs Performance Disclosure          
Name Adjusted EPS        
Measure:: 5          
Pay vs Performance Disclosure          
Name Free Cash Flow Conversion        
PEO | Equity Awards Adjustments          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 2,244,524        
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 7,500,182        
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (5,462,311)        
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 206,653        
PEO | Exclusion of Stock Awards and Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (10,254,137)        
Non-PEO NEO | Equity Awards Adjustments          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,197,167        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 2,282,894        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (1,094,425)        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 8,698        
Non-PEO NEO | Exclusion of Stock Awards and Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (2,820,390)        
v3.25.4
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2025
Award Timing Disclosures [Line Items]  
Award Timing MNPI Disclosure
Equity Award Granting Practices
The following practices apply to all of our equity awards, including grants made under our LTIP. Our 2009 Incentive Plan was approved by shareholders at our 2009 annual meeting of shareholders and reapproved by shareholders at our 2014 annual meeting of shareholders. Our 2019 Incentive Plan was approved by shareholders at our 2019 annual meeting of shareholders. Our 2009 Incentive Plan was the sole plan under which we granted equity awards from the date of its approval by shareholders until the approval of our 2019 Incentive Plan. The 2019 Incentive Plan has
been
the sole plan under which we grant equity awards since the date of its approval by shareholders.
 
These incentive plans provide for grants of stock options, restricted stock, stock appreciation rights, other stock unit awards, performance units, and cash performance awards. The plans give the committee the latitude to design cash and stock-based incentive programs that promote high performance and the achievement of corporate goals. Employees, including our named executive officers and
non-employee
directors, are eligible to receive awards under these plans.
We grant stock options on an annual basis to members of our management, including our executive officers, as well as certain other senior employees. We grant RSUs on an annual basis to our other employees. We may also grant stock options or RSUs to individuals upon hire or promotion or for retention purposes. We currently do not grant stock appreciation rights or similar option-like instruments. During the last fiscal year, neither our board nor the committee took material nonpublic information into account when determining the timing or terms of stock options,
nor did we time
the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.
While we do not have any policy or obligation that requires us to grant stock options on specified dates, our annual stock option grants are typically approved at the first committee meeting of each year with the approved grants becoming effective, and the option exercise price set, on the first day of the open trading window following the release of full-year earnings, which is the date of grant. Therefore, the annual grants typically take place after the release of material information regarding our annual financial performance. Option grants for new hires, and option grants that we make in connection with promotions or for retention purposes, typically become effective, with the option exercise price being set, on a grant date that is the 15
th
day of the month following the month of hire, promotion or determination to make the grant for retention purposes. During fiscal 2025, we did not grant stock options to any named
executive
officer
during
any period beginning four business days before and ending one business day after the filing of any Form
10-Q
or
10-K,
or the filing or furnishing of a Form
8-K
that disclosed material nonpublic information.
The stock option exercise price is set at the average of the high and low prices on the date of grant. We believe this practice results in a grant price which more fairly represents the stock price over the course of the date of grant than the closing price on the date of grant, which could be arbitrarily high or low.
Our board administers all equity grants within the authority established within Revvity’s shareholder-approved incentive plans and, as permitted under the plans, delegates authority to administer the plans to the committee. The committee establishes the terms and conditions of each award, including vesting and performance criteria, and the time period applicable to the award. The committee may delegate approval to grant equity awards to
non-officers
to our stock award grant committee of which Dr. Singh is the sole member. The stock award grant committee does not have the authority to issue equity grants to officers.
At the end of fiscal year 2025, we had 4.2 million shares reserved for future equity grants. We had 2.0 million outstanding options and unvested shares, which represent 1.8% of our common shares outstanding. Our total dilution including shares reserved for future grants and outstanding options and unvested shares was 5.5%. In 2025, we granted 0.15 million shares (including shares granted under options and RSUs) or 0.13% of our common shares outstanding. The committee annually reviews the potential dilutive effect of equity award programs from both a share and economic perspective as compared to industry peers. For fiscal year 2024, share dilution for our peer companies was 1.6% at the 25th percentile, 2.3% at median, and 3.3% at the 75
th
percentile (shares outstanding plus shares available for future grant).
Award Timing Predetermined true
Award Timing MNPI Considered false
Award Timing, How MNPI Considered During the last fiscal year, neither our board nor the committee took material nonpublic information into account when determining the timing or terms of stock options,
nor did we time
the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.
MNPI Disclosure Timed for Compensation Value false
v3.25.4
Insider Trading Policies and Procedures
 12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true